You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Merck Pembrolizumab (Keynote-117)

Showing 1 - 25 of 1,701
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for

Not yet recruiting
  • Carcinoma
  • +7 more
  • XNW5004
  • Pembrolizumab 25 mg/mL Solution for Injection
  • (no location specified)
Aug 31, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023

Metastatic Castration-Resistant Prostate Cancer Trial in Worldwide (biological, drug, other)

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • Pembrolizumab 200 mg
  • +11 more
  • Los Angeles, California
  • +30 more
Aug 12, 2022

Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

Recruiting
  • Advanced Malignancies
  • BI-1808
  • Pembrolizumab 25 Mg/mL Solution for Injection
  • Copenhagen, Denmark
  • +11 more
Sep 9, 2022

Melanoma Trial in Australia, United States (mRNA-4157, Pembrolizumab)

Active, not recruiting
  • Melanoma
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +21 more
Aug 23, 2022

Cancer Trial in Houston (LVGN6051)

Recruiting
  • Cancer
  • LVGN6051
  • Houston, Texas
    MD Anderson Cancer Center
Nov 18, 2021

Microsatellite Stable Colorectal Cancer Trial in United States (grapiprant, grapiprant and pembrolizumab)

Active, not recruiting
  • Microsatellite Stable Colorectal Cancer
  • Phoenix, Arizona
  • +3 more
Apr 21, 2022

NSCLC Trial in Worldwide (Pembrolizumab, Pemetrexed, Carboplatin)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Aurora, Colorado
  • +14 more
Oct 21, 2022

Hepatocellular Carcinoma, Liver Metastases, Cutaneous or Subcutaneous Lymph Node Trial in Worldwide (Talimogene Laherparepvec,

Active, not recruiting
Has Results
  • Hepatocellular Carcinoma
  • +3 more
  • Scottsdale, Arizona
  • +31 more
Dec 7, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Tucson, Arizona
  • +16 more
Nov 15, 2022

Head Neck Cancer Trial in Worldwide (Pembrolizumab, Epacadostat, Cetuximab)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Anaheim, California
  • +72 more
Jul 28, 2022

Endometrial Tumors Trial in Worldwide (Pembrolizumab, Lenvatinib, Paclitaxel)

Active, not recruiting
Has Results
  • Endometrial Neoplasms
  • Phoenix, Arizona
  • +168 more
Nov 23, 2022

Melanoma Trial (pembrolizumab, )

Active, not recruiting
Has Results
  • Melanoma
  • pembrolizumab
  • placebo
  • (no location specified)
Aug 18, 2022

NSCLC Trial in United States (NovoTTF-200T)

Recruiting
  • Non-small Cell Lung Cancer
  • NovoTTF-200T
  • Birmingham, Alabama
  • +21 more
Aug 15, 2022

Solid Tumors, GI Cancer Trial in Taiwan, United States (CGX1321, Pembrolizumab, encorafenib)

Recruiting
  • Solid Tumors
  • GI Cancer
  • Long Beach, California
  • +25 more
Jan 11, 2022

Stage III/IV Melanoma Trial in Worldwide (tavokinogene telseplasmid, Pembrolizumab, ImmunoPulse)

Recruiting
  • Stage III/IV Melanoma
  • tavokinogene telseplasmid
  • +2 more
  • Tucson, Arizona
  • +37 more
Dec 21, 2022

Carcinoma of the Head and Neck Trial in Worldwide (Talimogene Laherparepvec, Pembrolizumab)

Completed
Has Results
  • Carcinoma of the Head and Neck
  • Talimogene Laherparepvec
  • Pembrolizumab
  • Newark, Delaware
  • +32 more
Aug 13, 2021

Urothelial Cancer Trial (pembrolizumab)

Completed
Has Results
  • Urothelial Cancer
  • pembrolizumab
  • (no location specified)
Aug 18, 2022

Gastric Adenocarcinoma Trial (Pembrolizumab, Cisplatin, 5-FU)

Completed
Has Results
  • Gastric Adenocarcinoma
  • Pembrolizumab
  • +4 more
  • (no location specified)
Aug 18, 2022

Melanoma Trial in Worldwide (Pembrolizumab Dose C, Pembrolizumab Dose A, Pembrolizumab Dose B)

Active, not recruiting
  • Melanoma
  • Pembrolizumab Dose C
  • +3 more
  • Orange, New South Wales, Australia
  • +14 more
Jan 19, 2023

NSCLC Adenocarcinoma Trial in United States (grapiprant and pembrolizumab)

Terminated
  • Non-small Cell Lung Cancer Adenocarcinoma
  • grapiprant and pembrolizumab
  • Stanford, California
  • +5 more
Feb 19, 2021

Hodgkin Lymphoma Trial (pembrolizumab, brentuximab vedotin)

Active, not recruiting
  • Hodgkin Lymphoma
  • pembrolizumab
  • brentuximab vedotin
  • (no location specified)
Aug 18, 2022

Bladder Cancer Trial (pembrolizumab)

Active, not recruiting
  • Bladder Cancer
  • Pembrolizumab
  • +2 more
  • (no location specified)
Oct 11, 2022